Therapeutic potential of marine n-3 fatty acids in CABG patients

► No clear evidence for recommending specific treatment with n-3 PUFA in CABG. ► General recommendations for the secondary prevention with n-3 should be applied. ► There is no evidence to advise patients to stop taking n-3 PUFA prior to CABG. ► It is unclear whether intake of n-3 PUFA is associated with wound healing problems.